Vext Science, Inc.
VEXT
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.78% | 32.45% | 14.89% | 3.40% | -1.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.78% | 32.45% | 14.89% | 3.40% | -1.04% |
| Cost of Revenue | 35.60% | 19.87% | 15.01% | 18.60% | 27.10% |
| Gross Profit | 51.99% | 75.37% | 14.56% | -25.33% | -39.92% |
| SG&A Expenses | -31.47% | -30.30% | -18.61% | -17.66% | 89.87% |
| Depreciation & Amortization | 7.36% | 11.07% | 28.07% | 44.61% | 60.79% |
| Other Operating Expenses | 32,910.00% | 4,787.14% | 2,623.85% | 2,068.42% | 94.44% |
| Total Operating Expenses | 9.92% | 3.18% | 7.75% | 11.41% | 48.19% |
| Operating Income | 54.17% | 56.44% | 12.68% | -46.82% | -2,294.36% |
| Income Before Tax | -123.14% | -114.85% | -702.62% | -728.11% | -33.18% |
| Income Tax Expenses | 105.41% | 323.60% | 708.16% | 226.77% | 116.79% |
| Earnings from Continuing Operations | -119.39% | -138.30% | -867.87% | -610.05% | -250.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -119.39% | -138.30% | -867.87% | -610.05% | -250.00% |
| EBIT | 54.17% | 56.44% | 12.68% | -46.82% | -2,294.36% |
| EBITDA | 503.36% | 310.04% | 592.45% | 90.57% | -122.13% |
| EPS Basic | -129.69% | -113.06% | -695.96% | -599.47% | -180.49% |
| Normalized Basic EPS | 28.81% | 36.18% | -1.35% | -37.79% | -239.72% |
| EPS Diluted | -128.53% | -112.91% | -567.80% | -609.63% | -185.71% |
| Normalized Diluted EPS | 28.51% | 36.25% | -1.35% | -37.90% | -238.30% |
| Average Basic Shares Outstanding | 7.01% | 19.12% | 34.37% | 46.41% | 56.84% |
| Average Diluted Shares Outstanding | 6.51% | 19.31% | 34.50% | 46.56% | 57.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |